The Board of Directors of Malaysian Genomics Resource Centre Berhad has approved the change in the financial year end from 30 June to 31 December, in view that the current Board require more time to assess the information in the financial statements for year ended 30 June 2023, including financial and business development plans to finalise the financial statements and to ensure accuracy in the annual reporting moving forward. The current statements shall be from 1 July 2022 to 31 December 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 MYR | 0.00% | -2.22% | -1.12% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.12% | 12.88M | |
-16.99% | 8.55B | |
+65.23% | 4.24B | |
-1.63% | 2.54B | |
-41.76% | 2.35B | |
-8.53% | 1.89B | |
-19.29% | 1.55B | |
-39.61% | 1.23B | |
+9.54% | 1.13B | |
+19.57% | 955M |
- Stock Market
- Equities
- MGRC Stock
- News Malaysian Genomics Resource Centre
- Malaysian Genomics Resource Centre Berhad Announces Change in Financial Year End from 30 June to 31 December